Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from melanoma

Protein molecule link to melanoma outcomes

Melanoma patients who express a specific protein molecule are two-and-a-half times more likely to die within 10 years, South Australian researchers have found.

AAP

Eating fish has been linked to an increase in melanoma risk – but that doesn't mean we should take it off the menu

You wouldn’t expect fish and melanoma to be in the same headline – but they were last week. Researchers in the United States reported a higher risk of developing melanoma, a common type of potentially deadly skin cancer, in people who ate a relatively large amount of fish.

The Conversation

Deadly skin cancer linked to eating two portions of fish per week, study finds

The study suggests eating just two servings a week could increase the risk

Daily Record

From analysis to the latest developments in health,
read the most diverse news in one place.

Eating fish is linked to deadliest form of skin cancer

Just two portions a week could increase your risk, a study suggests

Wales Online

Eating two portions of fish a week linked to skin cancer, study suggests

US research identifies ‘association that requires further investigation’ – but some scientists aren’t convinced

The Independent UK

Eating two portions of fish per week linked to increased risk of skin cancer

The findings come from a study of nearly 500,000 participants

The Independent UK

Eating two portions of fish per week ‘linked to malignant melanoma’

US experts said their findings warranted investigation while others urged people not to stop eating fish.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Delcath Systems Stock Jumps After Data Update From Eye Cancer Trials At ASCO Meeting

Delcath Systems Inc (NASDAQ:DCTH) announced further details regarding presentations relating to its proprietary percutaneous hepatic perfusion (PHP) system. The CHOPIN trial assessed ipilimumab plus nivolumab (IPI+NIVO) combined with Delcath's proprietary liver-targeted PHP treatment in metastatic uveal melanoma patients. The poster reports a Best Overall Response of 1 complete response, five partial responses, and…

Benzinga

New research finds nearly a third of melanomas found during skin checks may not be harmful, improving treatment options

The discovery means skin checks are still important but paves the way for some "exciting" research possibilities to improve the diagnosis and treatment of the disease.

ABC News

80% of all cancers are on the skin. What happens if I have one?

Two in three Australians will have a skin cancer in their lifetime, nearly all of them basal cell carcinomas (BCC), squamous cell carcinomas (SCC) or melanomas.

The Conversation

The doctor says my mole is a melanoma. What happens next?

So your doctor removed a mole from your skin and now says it’s cancerous. What happens next?

The Conversation

County Durham mum whose itchy mole turned out to be skin cancer on how her story is helping others

Gill Liiv-Rochester, 36, from Seaham was diagnosed with two malignant melanomas in 2020

Chronicle Live

Doctor explains 'red flag' skin cancer signs to watch for on moles

Many don't know what to look out for but early treatment is essential for the best chance of survival

Wales Online

Doctor shares skin cancer 'red flag' signs on moles that could be early melanoma

Experts say the most common areas to develop skin cancer are different in men and women.

Daily Record

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

CHMP Supports Approval Of Merck's Keytruda As Adjuvant In Post Surgery Melanoma Setting

European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending Merck & Co Inc (NYSE:MRK) Keytruda in melanoma setting. The opinion covers Keytruda as a monotherapy adjuvant treatment for adults and adolescents aged 12 years and older with stage IIB or IIC melanoma and who have…

Benzinga

FDA Places Clinical Hold On Foghorn Therapeutics' Early-Stage Blood Cancer Trial

The FDA has instituted a clinical hold on Foghorn Therapeutics Inc's (NASDAQ:FHTX) Phase 1 dose-escalation study of FHD-286 in relapsed and/or refractory acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). The FDA initiated the partial clinical hold following the report of a recent death that occurred in a subject with potential differentiation syndrome. Differentiation…

The Guardian - AU

Ban on solariums in England would save hundreds of lives from skin cancer, study finds

Scientists who were instrumental in sunbeds being banned in Australia are helping UK researchers to try to reduce melanoma cases

Benzinga

IO Biotech Starts Dosing In Late-Stage IO102-IO103/Keytruda Combo Trial In Melanoma Patients

IO Biotech (NASDAQ: IOBT) dosed first patient in its phase 3 clinical trial of lead drug candidate, IO102-IO103, in combination with Merck's KEYTRUDA® (pembrolizumab) in patients with previously untreated, unresectable or metastatic (advanced) melanoma.

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

Check moles during Skin Cancer Awareness Month

MANKATO, Minn. — Learning your ABCs can alert you to changes in moles that could signal melanoma — the most serious type of skin cancer.

Daily Record

Banning sunbeds would save thousands from deadly skin cancer in UK, study shows

A ban on tanning beds could reduce the number of melanoma deaths, acording to a study led by University of Manchester researchers.

Glasgow Live

Experts voice skin cancer concerns as over a third of Scotland plan hot-climate holiday

35% of Scottish adults will be benefiting from the relaxed travel rules and are planning a hot summer holiday this year according to new data released today by the charity Melanoma Focus.

Daily Mirror

Skin cancer symptom warning: Signs on fingernails and toenails you should never ignore

There are many skin cancer warning signs and symptoms you should be aware of, as it's one of the most common types of cancer in the UK. One in particular can be spotted under a person's finger and toenails

Daily Record

Warning over skin cancer sign that can appear on your fingernails and toenails

Although rare, skin cancer, including melanoma - the deadliest form of skin cancer - can develop under and around the fingernails and toenails

Daily Record

Skin cancer symptoms as experts issue warning about summer holidays

People are putting themselves at risk of skin cancer - here's how to spot the key signs.

Benzinga

FDA Grants Orphan Drug Designation For IDEAYA's Darovasertib For Uveal Melanoma

The U.S. Food and Drug Administration (FDA) has granted orphan-drug designation to IDEAYA Biosciences (NASDAQ: IDYA) for its drug candidate Darovasertib for the treatment of uveal melanoma.

1 … 9 10 11 12

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

University of Manchester

129 stories

University of Queensland

European Medicines Agency

77 stories

US Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.